Cardiovascular preparticipation screening of competitive athletes. A statement for health professionals from the Sudden Death Committee (clinical cardiology) and Congenital Cardiac Defects Committee (cardiovascular disease in the young), American He
about
Sudden cardiac death athletes: a systematic reviewCoronary artery anomalies overview: The normal and the abnormalThe pre-participation examination for leisure time physical activity: general medical and cardiological issuesInter-association Task Force recommendations on emergency preparedness and management of sudden cardiac arrest in high school and college athletic programs: a consensus statementQuantification of regional myocardial wall motion by cardiovascular magnetic resonance.Screening for cardiovascular disease in the young.Echocardiographic differentiation of pathological and physiological left ventricular hypertrophyAnomalous origin of right coronary artery from left coronary sinus.Hypertrophic cardiomyopathy as a cause of sudden death.Anatomical criteria of malignancy by computed tomography angiography in patients with anomalous coronary arteries with an interarterial course.Anomalous Origin of Right Coronary Artery From Left Coronary Sinus-13 Cases Treated With the Reimplantation Technique.Chronic Endurance Exercise Impairs Cardiac Structure and Function in Middle-Aged Mice with Impaired Nrf2 Signaling.Electrocardiogram testing during athletic preparticipation physical examinationsCost-effectiveness of preparticipation screening for prevention of sudden cardiac death in young athletes.Congenital coronary anomalies detected by coronary computed tomography compared to invasive coronary angiography.Recognizing young people at risk for sudden cardiac death in preparticipation sports physicals.Sudden cardiac death in young athletes. Causes, athlete's heart, and screening guidelines.Athlete's heart electrocardiogram mimicking hypertrophic cardiomyopathy.SELDI-TOF-MS Serum Profiling Reveals Predictors of Cardiac MRI Changes in Marathon RunnersThe electrocardiographic abnormalities in highly trained athletes compared to the genetic study related to causes of unexpected sudden cardiac death.Rescue percutaneous transluminal coronary angioplasty in a patient with a single coronary artery arising from the right Sinus Valsalvae: previously unreported scenario and review of literature.A Review of Sudden Cardiac Death in Young Athletes and Strategies for Preparticipation Cardiovascular ScreeningSudden Cardiac Arrest in Athletic MedicinePreparticipation screening for the detection of cardiovascular abnormalities that may cause sudden death in competitive athletes.An echocardiographic assessment of cardiac morphology and common ECG findings in teenage professional soccer players: reference ranges for use in screening.Effects of nicotine administration in a mouse model of familial hypertrophic cardiomyopathy, α-tropomyosin D175N.Pre-participation Cardiovascular Screening of Elderly Wrestlers.Sudden cardiac death in young athletes; a literature review and special considerations in Asia.Aborted sudden cardiac death associated with an anomalous right coronary artery.Periodical cardiovascular screening is mandatory for elite athletes.Recovery from exercise: vulnerable state, window of opportunity, or crystal ball?cMRI-BED: A novel informatics framework for cardiac MRI biomarker extraction and discovery applied to pediatric cardiomyopathy classification.Screening athletes for heart diseaseCoronary artery anomalies Part II: recent insights from clinical investigations.What to do with hypertension and a murmur found during a preparticipation physical evaluation?National athletic trainers' association position statement: preventing sudden death in sports.Coronary artery anomalies and variants: technical feasibility of assessment with coronary MR angiography at 3 T.An integrated approach to determine left atrial volume, mass and function in hypertrophic cardiomyopathy by two-dimensional echocardiography.Preventing Sudden Cardiac Death: Automated External Defibrillators in Ohio High SchoolsSarcomeric proteins and familial hypertrophic cardiomyopathy: linking mutations in structural proteins to complex cardiovascular phenotypes.
P2860
Q21198776-2FB8B7D3-2FF2-487A-B448-BE544063BFB8Q27004694-BF472335-953A-494F-AACC-605B370947BDQ27692617-0F567C04-54BD-4753-BCE9-C07342A18FB7Q30229511-78A659F3-9204-48D1-A493-DB735685E72FQ30426382-65DD3B94-88C2-4DB7-8B11-AC891DD7A4DEQ30453075-A0EAA0EB-8539-455D-8612-33E5553167A6Q30542196-90A039E3-9EB3-412A-8412-97AAE81FC792Q33156500-F8239C76-95ED-4E41-9572-FEDE4497EB6AQ33157576-9F7DAEA7-DB00-4922-AFEE-4199BB6DB6B4Q33164850-C4CDD054-8012-4366-8A30-09C6EDBD518BQ33168650-8F5AB6D9-DF0C-43FF-B5B1-1345DDC9959AQ33627707-2AB77DB1-0D29-4D48-A190-55E1B2ACD2AAQ33835095-EADEE3CE-1CC3-4371-956F-7A4C4C95842AQ33862846-51CEB087-886A-4E1A-8D4F-F4DF0606159CQ33987834-0CD0F015-E87D-48EA-94EF-853FDCB10ACFQ34061390-DCF82643-5CB6-4B22-B0D7-AC1F28F1F2E1Q34066976-1F671B8B-F5FB-4265-8EDB-5DE5E0507E56Q34140789-1A888BE4-7F2A-4DBA-AEB0-3E830337D57AQ34417524-D2120A21-9709-4035-9003-51B0EC5C6DFCQ34481036-4ADCF492-E0C0-4AC8-B18F-22CA34DE53E5Q34696266-63B022BA-04CA-4889-9A89-D66079013A8CQ35008923-FF4527BF-4DC5-41D2-A002-1313EDEEBEC2Q35008933-86F5FDD0-8D00-4FC6-BBEC-8187347A52C8Q35325803-FFEA5ABB-814D-48E8-89CC-AA49D06BED02Q35379577-84A29520-AF14-4771-A05C-07948F442806Q35396585-1DD88307-E3B4-4CD6-AD4D-D691FA8C43AEQ35786498-F40751AC-6C47-4DC6-9D54-D215F9E740D6Q35786576-B2FA0527-C0E8-472E-97BF-396BF85ACD62Q35844245-C7FDFD90-BB10-4B03-B782-D08FCC889812Q35850761-D304A52C-A07D-4F7C-A845-E72BA8023D8CQ35877077-BB9470FA-D53C-427E-8347-944807BF5B3FQ35989549-19DB03F1-E27B-450C-8EEC-C59B93B273BDQ36014105-BC9194BC-D062-4A3C-965C-0E64F87D045DQ36019394-99A01DE3-6260-4D73-AC40-76AB80DBDE0BQ36093033-54E38E9B-4EA6-4261-8E12-78A2921A7DFDQ36161202-F916BCC5-F39A-4825-A67F-1756EC366E22Q36217838-D7A1220C-1CDF-4377-BB9C-D071DD81C8BAQ36237816-BF70ADDF-8B8A-4013-8343-5DD0A99D4BF8Q36270997-9530AE85-E64F-4F6A-943B-746A2F9CB601Q36369925-8E90B56B-2627-446C-AC05-8516F9615DE2
P2860
Cardiovascular preparticipation screening of competitive athletes. A statement for health professionals from the Sudden Death Committee (clinical cardiology) and Congenital Cardiac Defects Committee (cardiovascular disease in the young), American He
description
1996 nî lūn-bûn
@nan
1996 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
Cardiovascular preparticipatio ...... ase in the young), American He
@nl
type
label
Cardiovascular preparticipatio ...... ase in the young), American He
@nl
prefLabel
Cardiovascular preparticipatio ...... ase in the young), American He
@nl
P2093
P3181
P356
P1433
P1476
Cardiovascular preparticipatio ...... g), American Heart Association
@en
P2093
A E Epstein
C A McGrew
D J Driscoll
D L Atkins
J C Puffer
M H Crawford
M J Mitten
P D Thompson
P3181
P356
10.1161/01.CIR.94.4.850
P407
P577
1996-08-15T00:00:00Z